At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Behavioral: UR-GOAL communication toolbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
In Brief
A clinical study evaluating Behavioral: UR-GOAL communication tool for Acute Myeloid Leukemia. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myeloid Leukemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartOct 2021
Primary CompletionOct 2022
TodayJul 2026
First PostedNov 12, 2020
Enrollment StartOct 23, 2021
Primary CompletionOct 11, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 5.6 years ago
Interventions
Behavioral: UR-GOAL communication toolbehavioral
The UR-GOAL tool will incorporate conjoint analysis to elicit patient preferences as well as assessments of fitness and prognostic awarene